Preliminary studies had suggested possible problems with popular heartburn drugs – Prilosec and Nexium.
But U.S. government review of heartburn drugs Prilosec and Nexium found no evidence of increased heart risks.
The announcement followed a three-month safety review after reports of possible heart risks emerged from two preliminary studies. But detailed data from both studies, plus another 14 studies, showed no heightened risk associated with long-term use of the drugs, U. S. Food and Drug Administration officials said.
Both drugs Prilosec and Nexium are made by the British pharmaceutical company AstraZeneca.